Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles.

van der Weide H, Vermeulen-de Jongh DMC, van der Meijden A, Boers SA, Kreft D, Ten Kate MT, Falciani C, Pini A, Strandh M, Bakker-Woudenberg IAJM, Hays JP, Goessens WHF.

Int J Antimicrob Agents. 2019 Jun 5. pii: S0924-8579(19)30136-0. doi: 10.1016/j.ijantimicag.2019.05.019. [Epub ahead of print]

PMID:
31173867
2.

Differences in Systemic IgA Reactivity and Circulating Th Subsets in Healthy Volunteers With Specific Microbiota Enterotypes.

Grosserichter-Wagener C, Radjabzadeh D, van der Weide H, Smit KN, Kraaij R, Hays JP, van Zelm MC.

Front Immunol. 2019 Mar 7;10:341. doi: 10.3389/fimmu.2019.00341. eCollection 2019.

3.

Understanding and overcoming the pitfalls and biases of next-generation sequencing (NGS) methods for use in the routine clinical microbiological diagnostic laboratory.

Boers SA, Jansen R, Hays JP.

Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1059-1070. doi: 10.1007/s10096-019-03520-3. Epub 2019 Mar 5. Review.

4.

The successful uptake and sustainability of rapid infectious disease and antimicrobial resistance point-of-care testing requires a complex 'mix-and-match' implementation package.

Hays JP, Mitsakakis K, Luz S, van Belkum A, Becker K, van den Bruel A, Harbarth S, Rex JH, Simonsen GS, Werner G, Di Gregori V, Lüdke G, van Staa T, Moran-Gilad J, Bachmann TT; JPIAMR AMR-RDT consortium.

Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1015-1022. doi: 10.1007/s10096-019-03492-4. Epub 2019 Feb 2. Review.

5.

Antibiotic misuse in respiratory tract infections in children and adults-a prospective, multicentre study (TAILORED Treatment).

van Houten CB, Cohen A, Engelhard D, Hays JP, Karlsson R, Moore E, Fernández D, Kreisberg R, Collins LV, de Waal W, de Winter-de Groot KM, Wolfs TFW, Meijers P, Luijk B, Oosterheert JJ, Heijligenberg R, Sankatsing SUC, Bossink AWJ, Stubbs A, Stein M, Reisfeld S, Klein A, Rachmilevitch R, Ashkar J, Braverman I, Kartun V, Chistyakov I, Bamberger E, Srugo I, Odeh M, Schiff E, Dotan Y, Boico O, Navon R, Friedman T, Etshtein L, Paz M, Gottlieb TM, Pri-Or E, Kronenfeld G, Simon E, Oved K, Eden E, Bont LJ.

Eur J Clin Microbiol Infect Dis. 2019 Mar;38(3):505-514. doi: 10.1007/s10096-018-03454-2. Epub 2019 Feb 1.

6.

Galaxy mothur Toolset (GmT): a user-friendly application for 16S rRNA gene sequencing analysis using mothur.

Hiltemann SD, Boers SA, van der Spek PJ, Jansen R, Hays JP, Stubbs AP.

Gigascience. 2019 Feb 1;8(2). pii: giy166. doi: 10.1093/gigascience/giy166.

7.

Whole genome sequence analysis of NDM-1, CMY-4, and SHV-12 coproducing Salmonella enterica serovar Typhimurium isolated from a case of fatal burn wound infection.

Banerjee K, Sekar P, Krishnan P, Wattam AR, Roy S, Hays JP, Menezes GA.

Infect Drug Resist. 2018 Nov 28;11:2491-2495. doi: 10.2147/IDR.S167027. eCollection 2018.

8.

Antibiotic-nanomedicines: facing the challenge of effective treatment of antibiotic-resistant respiratory tract infections.

Ritsema JA, der Weide HV, Te Welscher YM, Goessens WH, van Nostrum CF, Storm G, Bakker-Woudenberg IA, Hays JP.

Future Microbiol. 2018 Nov;13:1683-1692. doi: 10.2217/fmb-2018-0194. Epub 2018 Nov 30.

PMID:
30499686
9.

Developmental roadmap for antimicrobial susceptibility testing systems.

van Belkum A, Bachmann TT, Lüdke G, Lisby JG, Kahlmeter G, Mohess A, Becker K, Hays JP, Woodford N, Mitsakakis K, Moran-Gilad J, Vila J, Peter H, Rex JH, Dunne WM Jr; JPIAMR AMR-RDT Working Group on Antimicrobial Resistance and Rapid Diagnostic Testing.

Nat Rev Microbiol. 2019 Jan;17(1):51-62. doi: 10.1038/s41579-018-0098-9. Review.

PMID:
30333569
10.

Monitoring of microbial dynamics in a drinking water distribution system using the culture-free, user-friendly, MYcrobiota platform.

Boers SA, Prest EI, Taučer-Kapteijn M, Knezev A, Schaap PG, Hays JP, Jansen R.

Sci Rep. 2018 Oct 3;8(1):14727. doi: 10.1038/s41598-018-32987-x.

11.

Detection of Bacterial DNA in Septic Arthritis Samples Using the MYcrobiota Platform.

Boers SA, Reijnen L, Herpers BL, Hays JP, Jansen R.

J Clin Rheumatol. 2018 Sep 21. doi: 10.1097/RHU.0000000000000901. [Epub ahead of print] No abstract available.

PMID:
30247225
12.

Challenges in identifying antibiotic resistance targets for point-of-care diagnostics in general practice.

Mitsakakis K, Kaman WE, Elshout G, Specht M, Hays JP.

Future Microbiol. 2018 Aug;13:1157-1164. doi: 10.2217/fmb-2018-0084. Epub 2018 Aug 16.

13.

Observational multi-centre, prospective study to characterize novel pathogen-and host-related factors in hospitalized patients with lower respiratory tract infections and/or sepsis - the "TAILORED-Treatment" study.

van Houten CB, Oved K, Eden E, Cohen A, Engelhard D, Boers S, Kraaij R, Karlsson R, Fernandez D, Gonzalez E, Li Y, Stubbs A, Moore ERB, Hays JP, Bont LJ.

BMC Infect Dis. 2018 Aug 7;18(1):377. doi: 10.1186/s12879-018-3300-9.

14.

Anthrax protective antigen is a calcium-dependent serine protease.

Storm L, Bikker FJ, Nazmi K, Hulst AG, der Riet-Van Oeveren DV, Veerman ECI, Hays JP, Kaman WE.

Virulence. 2018;9(1):1085-1091. doi: 10.1080/21505594.2018.1486139.

15.

Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance.

Croughs PD, Klaassen CHW, van Rosmalen J, Maghdid DM, Boers SA, Hays JP, Goessens WHF; Dutch Antibiotic Resistance Surveillance Group.

Int J Antimicrob Agents. 2018 Sep;52(3):407-410. doi: 10.1016/j.ijantimicag.2018.05.009. Epub 2018 May 15.

PMID:
29772393
16.

Development and evaluation of a culture-free microbiota profiling platform (MYcrobiota) for clinical diagnostics.

Boers SA, Hiltemann SD, Stubbs AP, Jansen R, Hays JP.

Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1081-1089. doi: 10.1007/s10096-018-3220-z. Epub 2018 Mar 16.

17.

Characterization of the nasopharyngeal and middle ear microbiota in gastroesophageal reflux-prone versus gastroesophageal reflux non-prone children.

Boers SA, de Zeeuw M, Jansen R, van der Schroeff MP, van Rossum AMC, Hays JP, Verhaegh SJC.

Eur J Clin Microbiol Infect Dis. 2018 May;37(5):851-857. doi: 10.1007/s10096-017-3178-2. Epub 2018 Feb 5.

18.

A Systematic Review of Lower Lip Anatomy, Mechanics of Local Flaps, and Special Considerations for Lower Lip Reconstruction.

Boukovalas S, Boson AL, Hays JP, Malone CH, Cole EL, Wagner RF.

J Drugs Dermatol. 2017 Dec 1;16(12):1254-1261. Review.

PMID:
29240861
19.

Interdomal sutures for nasal tip refinement and reduced wound size.

Malone CH, Hays JP, Tausend WE, Wagner RF Jr.

J Am Acad Dermatol. 2017 Oct;77(4):e107-e108. doi: 10.1016/j.jaad.2017.04.1115. No abstract available.

PMID:
28917475
20.

Reactive Eccrine Syringofibroadenoma Associated With Basal Cell Carcinoma: A Histologic Mimicker of Fibroepithelioma of Pinkus.

Hays JP, Malone CH, Goodwin BP, Wagner RF Jr.

Dermatol Surg. 2018 May;44(5):738-740. doi: 10.1097/DSS.0000000000001308. No abstract available.

PMID:
28902033
21.

Delayed Diagnosis of Basal Cell Carcinoma of the Upper Lip: The Possible Role of Incidental Multinucleated Foreign Body Giant Cells.

Hays JP, Malone CH, Tausend WE, Goodwin BP, Wagner RF Jr.

Case Rep Dermatol. 2017 Jun 16;9(2):50-54. doi: 10.1159/000477455. eCollection 2017 May-Aug.

22.

Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumon iae and P. aeruginosa.

van der Weide H, Brunetti J, Pini A, Bracci L, Ambrosini C, Lupetti P, Paccagnini E, Gentile M, Bernini A, Niccolai N, Jongh DV, Bakker-Woudenberg IAJM, Goessens WHF, Hays JP, Falciani C.

Biochim Biophys Acta Biomembr. 2017 Oct;1859(10):1796-1804. doi: 10.1016/j.bbamem.2017.06.001. Epub 2017 Jun 3.

23.

Why is scientific research on 'data-poor' microorganisms being ignored?

Hays JP.

Future Microbiol. 2017 Jun;12:645-650. doi: 10.2217/fmb-2017-0061. Epub 2017 May 25. No abstract available.

24.

Novel micelle PCR-based method for accurate, sensitive and quantitative microbiota profiling.

Boers SA, Hays JP, Jansen R.

Sci Rep. 2017 Apr 5;7:45536. doi: 10.1038/srep45536.

25.

Pre-implementation guidelines for infectious disease point-of-care testing in medical institutions.

van der Eijk AA, Tintu AN, Hays JP.

Future Microbiol. 2017 Jan;12:51-58. doi: 10.2217/fmb-2016-0120. Epub 2016 Dec 6.

26.

Evaluation of the characteristics of leucyl-tRNA synthetase (LeuRS) inhibitor AN3365 in combination with different antibiotic classes.

Monteferrante CG, Jirgensons A, Varik V, Hauryliuk V, Goessens WH, Hays JP.

Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1857-1864. Epub 2016 Aug 9.

27.

'Out-of-the-box' thinking to help stop the spread of antibiotic resistance.

Hays JP.

Future Microbiol. 2016 Aug;11:995-8. doi: 10.2217/fmb-2016-0121. Epub 2016 Jul 29. No abstract available.

28.

Detection of Healthcare-Related Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Transmission Events Using Combined Genetic and Phenotypic Epidemiology.

Voor In 't Holt AF, Wattel AA, Boers SA, Jansen R, Hays JP, Goessens WH, Vos MC.

PLoS One. 2016 Jul 27;11(7):e0160156. doi: 10.1371/journal.pone.0160156. eCollection 2016.

29.

Chair/bedside diagnosis of oral and respiratory tract infections, and identification of antibiotic resistances for personalised monitoring and treatment.

Mitsakakis K, Stumpf F, Strohmeier O, Klein V, Mark D, Von Stetten F, Peham JR, Herz C, Tawakoli PN, Wegehaupt F, Attin T, Bostanci N, Bao K, Belibasakis GN, Hays JP, Elshout G, Huisman RC, Klein S, Stubbs AP, Doms L, Wolf A, Rusu V, Goethel S, Binsl T, Michie A, Jancovicova J, Kolar V, Kostka M, Smutny J, Karpisek M, Estephan C, Cocaud C, Zengerle R.

Stud Health Technol Inform. 2016;224:61-6.

30.

Current problems associated with the microbiological point-of-care testing of respiratory tract infections in primary care.

Kaman WE, Elshout G, Bindels PJ, Mitsakakis K, Hays JP.

Future Microbiol. 2016 May;11:607-10. doi: 10.2217/fmb-2015-0020. No abstract available.

31.

Suddenly everyone is a microbiota specialist.

Boers SA, Jansen R, Hays JP.

Clin Microbiol Infect. 2016 Jul;22(7):581-2. doi: 10.1016/j.cmi.2016.05.002. Epub 2016 May 13. No abstract available.

32.

Detection of amino acid substitutions in the GyrA protein of fluoroquinolone-resistant typhoidal Salmonella isolates using high-resolution mass spectrometry.

Hassing RJ, Goessens WH, Zeneyedpour L, Sultan S, van Kampen JJ, Verbon A, van Genderen PJ, Hays JP, Luider TM, Dekker LJ.

Int J Antimicrob Agents. 2016 May;47(5):351-6. doi: 10.1016/j.ijantimicag.2016.01.018. Epub 2016 Mar 15.

PMID:
27132191
33.

Antimicrobial resistance trends in blood culture positive Salmonella Paratyphi A isolates from Pondicherry, India.

Menezes GA, Harish BN, Khan MA, Goessens W, Hays JP.

Indian J Med Microbiol. 2016 Apr-Jun;34(2):222-7. doi: 10.4103/0255-0857.180352.

34.

A Polymorphism in leuS Confers Reduced Susceptibility to GSK2251052 in a Clinical Isolate of Staphylococcus aureus.

Gupta A, Monteferrante C, Rasina D, Leitis G, Randall CP, Tomlinson JH, Jirgensons A, Goessens WH, Hays JP, O'Neill AJ.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3219-21. doi: 10.1128/AAC.02940-15. Print 2016 May.

35.

FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL.

Reeves PT, Herndon DN, Tanksley JD, Jennings K, Klein GL, Mlcak RP, Clayton RP, Crites NN, Hays JP, Andersen C, Lee JO, Meyer W, Suman OE, Finnerty CC.

Shock. 2016 Apr;45(4):367-74. doi: 10.1097/SHK.0000000000000517.

36.

Micelle PCR reduces chimera formation in 16S rRNA profiling of complex microbial DNA mixtures.

Boers SA, Hays JP, Jansen R.

Sci Rep. 2015 Sep 16;5:14181. doi: 10.1038/srep14181.

37.

A multifaceted 'omics' approach for addressing the challenge of antimicrobial resistance.

Cohen A, Bont L, Engelhard D, Moore E, Fernández D, Kreisberg-Greenblatt R, Oved K, Eden E, Hays JP.

Future Microbiol. 2015;10(3):365-76. doi: 10.2217/fmb.14.127.

38.

Plasmid-mediated AmpC: prevalence in community-acquired isolates in Amsterdam, the Netherlands, and risk factors for carriage.

Reuland EA, Halaby T, Hays JP, de Jongh DM, Snetselaar HD, van Keulen M, Elders PJ, Savelkoul PH, Vandenbroucke-Grauls CM, Al Naiemi N.

PLoS One. 2015 Jan 14;10(1):e0113033. doi: 10.1371/journal.pone.0113033. eCollection 2015.

39.

Whole-genome mapping for high-resolution genotyping of Pseudomonas aeruginosa.

Boers SA, Burggrave R, van Westreenen M, Goessens WHF, Hays JP.

J Microbiol Methods. 2014 Nov;106:19-22. doi: 10.1016/j.mimet.2014.07.020. Epub 2014 Aug 10.

PMID:
25119380
40.

Detection and occurrence of plasmid-mediated AmpC in highly resistant gram-negative rods.

Reuland EA, Hays JP, de Jongh DM, Abdelrehim E, Willemsen I, Kluytmans JA, Savelkoul PH, Vandenbroucke-Grauls CM, al Naiemi N.

PLoS One. 2014 Mar 18;9(3):e91396. doi: 10.1371/journal.pone.0091396. eCollection 2014.

41.

Bacterial proteases: targets for diagnostics and therapy.

Kaman WE, Hays JP, Endtz HP, Bikker FJ.

Eur J Clin Microbiol Infect Dis. 2014 Jul;33(7):1081-7. doi: 10.1007/s10096-014-2075-1. Epub 2014 Feb 18. Review.

PMID:
24535571
42.

Evaluation of a FRET-peptide substrate to predict virulence in Pseudomonas aeruginosa.

Kaman WE, Arkoubi-El Arkoubi NE, Roffel S, Endtz HP, van Belkum A, Bikker FJ, Hays JP.

PLoS One. 2013 Nov 26;8(11):e81428. doi: 10.1371/journal.pone.0081428. eCollection 2013.

43.

Evaluation of a D-amino-acid-containing fluorescence resonance energy transfer peptide library for profiling prokaryotic proteases.

Kaman WE, Voskamp-Visser I, de Jongh DM, Endtz HP, van Belkum A, Hays JP, Bikker FJ.

Anal Biochem. 2013 Oct 1;441(1):38-43. doi: 10.1016/j.ab.2013.06.015. Epub 2013 Jul 10.

PMID:
23850560
44.

Perceptions of point-of-care infectious disease testing among European medical personnel, point-of-care test kit manufacturers, and the general public.

Kaman WE, Andrinopoulou ER, Hays JP.

Patient Prefer Adherence. 2013 Jun 19;7:559-77. doi: 10.2147/PPA.S44889. Print 2013.

45.

Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model.

Smidt M, Bättig P, Verhaegh SJ, Niebisch A, Hanner M, Selak S, Schüler W, Morfeldt E, Hellberg C, Nagy E, Lundberg U, Hays JP, Meinke A, Henriques-Normark B.

PLoS One. 2013 May 9;8(5):e64422. doi: 10.1371/journal.pone.0064422. Print 2013.

46.

Differential virulence gene expression of group A Streptococcus serotype M3 in response to co-culture with Moraxella catarrhalis.

Verhaegh SJ, Flores AR, van Belkum A, Musser JM, Hays JP.

PLoS One. 2013 Apr 23;8(4):e62549. doi: 10.1371/journal.pone.0062549. Print 2013.

47.

The papain inhibitor (SPI) of Streptomyces mobaraensis inhibits bacterial cysteine proteases and is an antagonist of bacterial growth.

Zindel S, Kaman WE, Fröls S, Pfeifer F, Peters A, Hays JP, Fuchsbauer HL.

Antimicrob Agents Chemother. 2013 Jul;57(7):3388-91. doi: 10.1128/AAC.00129-13. Epub 2013 Apr 15.

48.

Microbial profiling does not differentiate between childhood recurrent acute otitis media and chronic otitis media with effusion.

Stol K, Verhaegh SJ, Graamans K, Engel JA, Sturm PD, Melchers WJ, Meis JF, Warris A, Hays JP, Hermans PW.

Int J Pediatr Otorhinolaryngol. 2013 Apr;77(4):488-93. doi: 10.1016/j.ijporl.2012.12.016. Epub 2013 Jan 29.

49.

New type F lineage-related Tn1546 and a vanA/vanB type vancomycin-resistant Enterococcus faecium isolated from patients in Dammam, Saudi Arabia during 2006-2007.

Khan MA, Shorman M, Al-Tawfiq JA, Hays JP.

Epidemiol Infect. 2013 May;141(5):1109-14. doi: 10.1017/S0950268812001574. Epub 2012 Jul 26. Erratum in: Epidemiol Infect. 2013 May;141(5):1115. Al-Tawfiq, J [corrected to Al-Tawfiq, J A].

PMID:
22831856
50.

Inflammation in the middle ear of children with recurrent or chronic otitis media is associated with bacterial load.

Stol K, Diavatopoulos DA, Graamans K, Engel JA, Melchers WJ, Savelkoul HF, Hays JP, Warris A, Hermans PW.

Pediatr Infect Dis J. 2012 Nov;31(11):1128-34. doi: 10.1097/INF.0b013e3182611d6b.

PMID:
22668804

Supplemental Content

Support Center